uniQure
QURE
#4278
Rank
HK$22.54 B
Marketcap
HK$327.92
Share price
-7.44%
Change (1 day)
191.94%
Change (1 year)

uniQure (QURE) - Cash on Hand

Cash on Hand as of March 2026 : HK$4.60 Billion

According to uniQure's latest financial reports the company has HK$4.60 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

uniQure - Cash on Hand chart (from 2012 to 2026)

Cash on Hand by year

Year Cash on Hand Change
2025-12-31HK$4.84 B69.76%
2024-12-31HK$2.85 B-40.87%
2023-12-31HK$4.82 B75.05%
2022-12-31HK$2.75 B-36.44%
2021-12-31HK$4.33 B128.44%
2020-12-31HK$1.89 B-35.47%
2019-12-31HK$2.94 B59.95%
2018-12-31HK$1.83 B47.73%
2017-12-31HK$1.24 B21.19%
2016-12-31HK$1.02 B-40.19%
2015-12-31HK$1.71 B242.21%
2014-12-31HK$0.50 B96.88%
2013-12-31HK$0.25 B9356.62%
2012-12-31HK$2.69 M-75.65%
2011-12-31HK$11.07 M-94.01%
2010-12-31HK$0.18 B

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Amgen
AMGN
HK$94.41 B 1,952.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
HK$50.32 B 993.98%๐Ÿ‡ซ๐Ÿ‡ท France
Sangamo Therapeutics
SGMO
HK$0.23 B-94.95%๐Ÿ‡บ๐Ÿ‡ธ USA
bluebird bio
BLUE
HK$0.61 B-86.58%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
HK$17.43 B 278.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Avidity Biosciences
RNAM
HK$13.30 B 189.30%๐Ÿ‡บ๐Ÿ‡ธ USA